Human Stem Cell Institute (MICEX: ISKJ, Russia) HSCI just got an authorization for sales of
the first gene therapy drug in Russia.
The first gene therapy drug was approved on the Russian market on December 7.
Not exact matches
Approved treatments included
gene therapies and the
first new
drugs for rare diseases in many years.
In science news around the world, NASA's Cassini mission is about to take its final plunge into the atmosphere of Saturn after 13 years providing an unprecedented view of the planet and its moons, a fight over whether to preserve or develop of one Europe's oldest gold mining sites heats up again, the U.S. Food and
Drug Administration approves the
first cancer
gene therapy for people, a U.S. court gives a green light to a $ 1 billion lawsuit brought by the Guatemalan victims and survivors of mid — 20th century syphilis experiments by research institutions including Johns Hopkins University, and more.
Barroso spent his
first year at GSK's Biopharmaceuticals Centre of Excellence for
Drug Discovery near London looking at the use of adenoviruses in
gene - transfer
therapy.
A
first - of - its - kind
gene therapy received approval from the Food and
Drug Administration on Tuesday to treat a rare, inherited form of childhood blindness.
These so - called «living
drugs» — injected T cells genetically modified to better recognize and kill tumor cells through a perpetual process of cell renewal and expansion — are revolutionizing cancer treatment, with the
first two FDA approvals of such
gene - altering
therapies occurring in just the last two months.
Endari, the
first new treatment for patients with sickle cell disease in almost 20 years, Genentech's Hemlibra, the
first - ever non-blood product to treat patients with hemophilia A with inhibitors, Actemra, the
first treatment for adults diagnosed with giant cell arteritis, BioMarin's Brineura, the
first treatment for a form of Batten disease, Benznidazole, the
first U.S. treatment for Chagas disease, Novartis» Kymriah to treat certain children and young adults with B - cell acute lymphoblastic leukemia, which is also the
first gene therapy to become available in the United States, are some of the
drugs that received the FDA's stamp of approval in 2017.
The U.S. Food and
Drug Administration on Aug. 30 approved the
first - ever
gene therapy to treat children and young adults with leukemia.
University of Pennsylvania immunotherapy researcher Dr. Carl June, who led the development of an experimental
therapy for advanced childhood leukemia that is expected to become the first CAR T - cell therapy to win U.S. Food and Drug Administration approval, will give the keynote talk today at the Conference on Cell & Gene Therapy for HIV Cure at Fred Hutchinson Cancer Research
therapy for advanced childhood leukemia that is expected to become the
first CAR T - cell
therapy to win U.S. Food and Drug Administration approval, will give the keynote talk today at the Conference on Cell & Gene Therapy for HIV Cure at Fred Hutchinson Cancer Research
therapy to win U.S. Food and
Drug Administration approval, will give the keynote talk today at the Conference on Cell &
Gene Therapy for HIV Cure at Fred Hutchinson Cancer Research
Therapy for HIV Cure at Fred Hutchinson Cancer Research Center.